• 2290 Citations
  • 19 h-Index
20132019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2013 2019

Filter
Letter
2014
6 Citations (Scopus)

High-throughput drug screening identifies compounds and molecular strategies for targeting proteasome inhibitor-resistant multiple myeloma

Stessman, H., Lulla, A., Xia, T., Mitra, A., Harding, T., Mansoor, A., Myers, C. L., Van Ness, B. G. & Dolloff, N. G., Nov 1 2014, In : Leukemia. 28, 11, p. 2263-2267 5 p.

Research output: Contribution to journalLetter

Neoplasm Drug Resistance
Boronic Acids
High-Throughput Screening Assays
Cultured Tumor Cells
Pyrazines

Stabilization of activation induced cytidine deaminase by bortezomib does not confer increased drug target mutation frequency

Stessman, H., Mansoor, A., Linden, M. A., Van Ness, B. & Baughn, L. B., Jan 1 2014, In : Leukemia and Lymphoma. 55, 1, p. 220-222 3 p.

Research output: Contribution to journalLetter

Neoplasm Drug Resistance
Boronic Acids
Cytidine Deaminase
Pyrazines
Enzyme Activation
2013
26 Citations (Scopus)

Reduced CXCR4 expression is associated with extramedullary disease in a mouse model of myeloma and predicts poor survival in multiple myeloma patients treated with bortezomib

Stessman, H., Mansoor, A., Zhan, F., Janz, S., Linden, M. A., Baughn, L. B. & Van Ness, B., Oct 1 2013, In : Leukemia. 27, 10, p. 2075-2077 3 p.

Research output: Contribution to journalLetter

Neoplasm Drug Resistance
Boronic Acids
Myeloid Sarcoma
CXCR4 Receptors
Pyrazines